» Articles » PMID: 14966567

Enhanced Neuronal Excitability in the Absence of Neurodegeneration Induces Cerebellar Ataxia

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2004 Feb 18
PMID 14966567
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebellar ataxia, a devastating neurological disease, may be initiated by hyperexcitability of deep cerebellar nuclei (DCN) secondary to loss of inhibitory input from Purkinje neurons that frequently degenerate in this disease. This mechanism predicts that intrinsic DCN hyperexcitability would cause ataxia in the absence of upstream Purkinje degeneration. We report the generation of a transgenic (Tg) model that supports this mechanism of disease initiation. Small-conductance calcium-activated potassium (SK) channels, regulators of firing frequency, were silenced in the CNS of Tg mice with the dominant-inhibitory construct SK3-1B-GFP. Transgene expression was restricted to the DCN within the cerebellum and was detectable beginning on postnatal day 10, concomitant with the onset of cerebellar ataxia. Neurodegeneration was not evident up to the sixth month of age. Recordings from Tg DCN neurons revealed loss of the apamin-sensitive after-hyperpolarization current (IAHP) and increased spontaneous firing through SK channel suppression, indicative of DCN hyperexcitability. Spike duration and other electrogenic conductance were unaffected. Thus, a purely electrical alteration is sufficient to cause cerebellar ataxia, and SK openers such as the neuroprotective agent riluzole may reduce neuronal hyperexcitability and have therapeutic value. This dominant-inhibitory strategy may help define the in vivo role of SK channels in other neuronal pathways.

Citing Articles

Long-Term Follow-Up before and during Riluzole Treatment in Six Patients from Two Families with Spinocerebellar Ataxia Type 7.

Suppiej A, Ceccato C, Tzekov R, Cermakova I, Parmeggiani F, Bellucci G Cerebellum. 2024; 23(6):2226-2235.

PMID: 38976217 PMC: 11585522. DOI: 10.1007/s12311-024-01714-w.


Viewpoint: spinocerebellar ataxias as diseases of Purkinje cell dysfunction rather than Purkinje cell loss.

Kapfhammer J, Shimobayashi E Front Mol Neurosci. 2023; 16:1182431.

PMID: 37426070 PMC: 10323145. DOI: 10.3389/fnmol.2023.1182431.


Targeting Ion Channels and Purkinje Neuron Intrinsic Membrane Excitability as a Therapeutic Strategy for Cerebellar Ataxia.

Huang H, Shakkottai V Life (Basel). 2023; 13(6).

PMID: 37374132 PMC: 10302946. DOI: 10.3390/life13061350.


Cerebellar granule cell signaling is indispensable for normal motor performance.

Lee J, Khan M, Stark A, Seo S, Norton A, Yao Z Cell Rep. 2023; 42(5):112429.

PMID: 37141091 PMC: 10258556. DOI: 10.1016/j.celrep.2023.112429.


K-Related Neurological Disorders: Phenotypic Spectrum and Therapeutic Indications.

Zahra A, Liu R, Han W, Meng H, Wang Q, Wang Y Curr Neuropharmacol. 2022; 21(7):1504-1518.

PMID: 36503451 PMC: 10472807. DOI: 10.2174/1570159X21666221208091805.


References
1.
Zeilhofer H, Blank N, Neuhuber W, Swandulla D . Calcium-dependent inactivation of neuronal calcium channel currents is independent of calcineurin. Neuroscience. 2000; 95(1):235-41. DOI: 10.1016/s0306-4522(99)00434-0. View

2.
Telgkamp P, Raman I . Depression of inhibitory synaptic transmission between Purkinje cells and neurons of the cerebellar nuclei. J Neurosci. 2002; 22(19):8447-57. PMC: 6757792. View

3.
Sultan F, Konig T, Mock M, Thier P . Quantitative organization of neurotransmitters in the deep cerebellar nuclei of the Lurcher mutant. J Comp Neurol. 2002; 452(4):311-23. DOI: 10.1002/cne.10365. View

4.
Sailer C, Hu H, Kaufmann W, Trieb M, Schwarzer C, Storm J . Regional differences in distribution and functional expression of small-conductance Ca2+-activated K+ channels in rat brain. J Neurosci. 2002; 22(22):9698-707. PMC: 6757844. View

5.
Tomita H, Shakkottai V, Gutman G, Sun G, Bunney W, Cahalan M . Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol Psychiatry. 2003; 8(5):524-35, 460. DOI: 10.1038/sj.mp.4001271. View